Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25:262–84.

Article  PubMed  PubMed Central  Google Scholar 

Murray AJ, Knight NS, Cole MA, et al. Novel ketone diet enhances physical and cognitive performance. Faseb J. 2016;30:4021–32.

Article  PubMed  PubMed Central  Google Scholar 

Voros G, Ector J, Garweg C, et al. Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic left ventricular remodeling. Circ Heart Fail. 2018;11:e004953.

Article  PubMed  Google Scholar 

Chapter 1: CKD in the general population. Am J Kidney Dis. 2019;73:S1–S28.

Chronic Kidney Disease and Risk Management. Standards of care in diabetes—2024. Diabetes Care. 2024;47:S219–30.

Article  Google Scholar 

Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57:1446–54.

Article  PubMed  Google Scholar 

Mima A. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets. J Diabetes Res. 2013;2013:248563.

Article  PubMed  PubMed Central  Google Scholar 

Liu WJ, Huang WF, Ye L, et al. The activity and role of autophagy in the pathogenesis of diabetic nephropathy. Eur Rev Med Pharmacol Sci. 2018;22:3182–9.

PubMed  Google Scholar 

Sanajou D, Ghorbani Haghjo A, Argani H, Aslani S. Age-rage axis blockade in diabetic nephropathy: current status and future directions. Eur J Pharmacol. 2018;833:158–64.

Article  PubMed  Google Scholar 

Tsai YC, Kuo MC, Hung WW, et al. High glucose induces mesangial cell apoptosis through miR-15b-5p and promotes diabetic nephropathy by extracellular vesicle delivery. Mol Ther. 2020;28:963–74.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Wang J, Xu F, et al. A J-shaped relationship between ketones and the risk of diabetic kidney disease in patients with type 2 diabetes: new insights from a cross-sectional study. Diabetes Obes Metab. 2023;25:3317–26.

Article  PubMed  Google Scholar 

Li Y, Zhang Y, Shen X, Zhao F, Yan S. The value of ketone bodies in the evaluation of kidney function in patients with type 2 diabetes mellitus. J Diabetes Res. 2021;2021:5596125.

Article  PubMed  PubMed Central  Google Scholar 

Goligorsky MS. Chronic kidney disease: a vicarious relation to premature cell senescence. Am J Pathol. 2020;190:1164–71.

Article  PubMed  PubMed Central  Google Scholar 

Lee M, Cho Y, Lee YH, Kang ES, Cha BS, Lee BW. β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months. Diabetes Metab. 2023;49:101427.

Article  PubMed  Google Scholar 

Hwang YC, Kim JH, Lee BW, Lee WJ. A lower baseline urinary glucose excretion predicts a better response to the sodium glucose cotransporter 2 inhibitor. Diabetes Metab J. 2019;43:898–905.

Article  PubMed  PubMed Central  Google Scholar 

Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.

Article  PubMed  Google Scholar 

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.

Article  PubMed  Google Scholar 

Seltzer HS, Allen EW, Herron AL Jr, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest. 1967;46:323–35.

Article  PubMed  PubMed Central  Google Scholar 

Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–10.

Article  PubMed  Google Scholar 

Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–100.

Article  PubMed  Google Scholar 

Shaw AB, Risdon P, Lewis-Jackson JD. Protein creatinine index and albustix in assessment of proteinuria. Br Med J (Clin Res Ed). 1983;287:929–32.

Article  PubMed  Google Scholar 

Halimi JM, Matthias B, Al-Najjar A, et al. Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients. Am J Transplant. 2007;7:2775–81.

Article  PubMed  Google Scholar 

Kim JH, Oh SY, Kim EH, et al. Addition of nonalbumin proteinuria to albuminuria improves prediction of type 2 diabetic nephropathy progression. Diabetol Metab Syndr. 2017;9:68.

Article  PubMed  PubMed Central  Google Scholar 

Nakayama H, Tokubuchi I, Wada N, et al. Age-related changes in the diurnal variation of ketogenesis in patients with type 2 diabetes and relevance to hypoglycemic medications. Endocr J. 2015;62:235–41.

Article  PubMed  Google Scholar 

Mima A, Nomura A, Fujii T. Current findings on the efficacy of incretin-based drugs for diabetic kidney disease: a narrative review. Biomed Pharmacother. 2023;165:115032.

Article  PubMed  Google Scholar 

Mima A, Nomura A, Yasuzawa T. Update on the pathophysiology and treatment of diabetic kidney disease: a narrative review. Expert Rev Clin Immunol. 2025;21:921–8.

Article  PubMed  Google Scholar 

Suzuki M, Kosegawa I, Miura S, et al. Blood ketone bodies in NIDDM: relationship with diabetic control and endogenous insulin secretion. Diabetes Res. 1991;18:11–7.

PubMed  Google Scholar 

Moeller MJ, Tenten V. Renal albumin filtration: alternative models to the standard physical barriers. Nat Rev Nephrol. 2013;9:266–77.

Article  PubMed  Google Scholar 

Methven S, MacGregor MS, Traynor JP, Hair M, O’Reilly DS, Deighan CJ. Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD. Am J Kidney Dis. 2011;57:21–8.

Article  PubMed  Google Scholar 

Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol. 2011;300:R1009–22.

Article  PubMed  Google Scholar 

Yacoub R, Campbell KN. Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis. 2015;8:29–40.

PubMed  PubMed Central  Google Scholar 

Forrester SJ, Kawai T, O’Brien S, Thomas W, Harris RC, Eguchi S. Epidermal growth factor receptor transactivation: mechanisms, pathophysiology, and potential therapies in the cardiovascular system. Annu Rev Pharmacol Toxicol. 2016;56:627–53.

Article  PubMed  Google Scholar 

Gilbert RE. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes. 2017;66:791–800.

Article  PubMed  Google Scholar 

Bae J, Won YJ, Lee BW. Non-albumin proteinuria (NAP) as a complementary marker for diabetic kidney disease (DKD). Life. 2021. https://doi.org/10.3390/life11030224.

Article  PubMed  PubMed Central  Google Scholar 

De Nicola L, Gabbai FB, Liberti ME, Sagliocca A, Conte G, Minutolo R. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes. Am J Kidney Dis. 2014;64:16–24.

Article  PubMed  Google Scholar 

Jeon YK, Kim MR, Huh JE, et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. J Korean Med Sci. 2011;26:258–63.

Article  PubMed  PubMed Central